LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today reported third ...
(Reuters) -Voyager Technologies secured a valuation of $3.8 billion after the defense and space firm's shares more than doubled in their U.S. debut, signalling strong interest in the sector expected ...
After 47 years it’s little wonder that the hydrazine-powered thrusters of the Voyager 1, used to orient the spacecraft in such a way that its 3.7 meter (12 foot) diameter antenna always points back ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results